Abeona Therapeutics Inc. diskutieren
Abeona Therapeutics Inc.
WKN: A3DMHM / Symbol: ABEO / Name: Abeona Therapeutics / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
5,30 €
2,78 %
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $38.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $36.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its price target lowered by analysts at Cantor Fitzgerald from $28.00 to $21.00. They now have an "overweight" rating on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $15.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $18.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Neueste Beiträge
B__Riley in Matthews International Corp. diskutieren